Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 15.9 HKD 2.45% Market Closed
Market Cap: 5.2B HKD

Zylox-Tonbridge Medical Technology Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zylox-Tonbridge Medical Technology Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Net Income (Common)
-ÂĄ78.7m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Net Income (Common)
ÂĄ533.9m
CAGR 3-Years
69%
CAGR 5-Years
90%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Net Income (Common)
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Net Income (Common)
ÂĄ12.4B
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Net Income (Common)
ÂĄ707.3m
CAGR 3-Years
-26%
CAGR 5-Years
-16%
CAGR 10-Years
6%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Net Income (Common)
ÂĄ2B
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Zylox-Tonbridge Medical Technology Co Ltd
Glance View

Market Cap
5.2B HKD
Industry
Health Care

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

Intrinsic Value
19.22 HKD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Zylox-Tonbridge Medical Technology Co Ltd's Net Income (Common)?
Net Income (Common)
-78.7m CNY

Based on the financial report for Dec 31, 2023, Zylox-Tonbridge Medical Technology Co Ltd's Net Income (Common) amounts to -78.7m CNY.

What is Zylox-Tonbridge Medical Technology Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
8%

Over the last year, the Net Income (Common) growth was 31%. The average annual Net Income (Common) growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been 8% over the past three years .

Back to Top